PRKCD and Parkinson disease: For example, PKCδ may be proteolytically activated by caspase-3, which is crucial for apoptosis induced by 1-methyl-4-phenylpyridinium (MPP+), a pharmacological model mimicking Parkinson’s disease (PD).